Reuters logo
BRIEF-Nektar Therapeutics reports Q1 revenue $24.7 million
May 9, 2017 / 9:48 PM / 7 months ago

BRIEF-Nektar Therapeutics reports Q1 revenue $24.7 million

May 9 (Reuters) - Nektar Therapeutics

* Nektar Therapeutics reports financial results for the first quarter of 2017

* Q1 loss per share $0.42

* Q1 revenue $24.7 million versus I/B/E/S view $26.8 million

* Q1 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below